Department of Epidemiology, School of Public Health, University of Washington, Seattle, USA.
Am J Epidemiol. 2012 May 1;175(9):962-9. doi: 10.1093/aje/kwr441. Epub 2012 Apr 5.
Scientific research has shifted from studies conducted by single investigators to the creation of large consortia. Genetic epidemiologists, for example, now collaborate extensively for genome-wide association studies (GWAS). The effect has been a stream of confirmed disease-gene associations. However, effects on human subjects oversight, data-sharing, publication and authorship practices, research organization and productivity, and intellectual property remain to be examined. The aim of this analysis was to identify all research consortia that had published the results of a GWAS analysis since 2005, characterize them, determine which have publicly accessible guidelines for research practices, and summarize the policies in these guidelines. A review of the National Human Genome Research Institute's Catalog of Published Genome-Wide Association Studies identified 55 GWAS consortia as of April 1, 2011. These consortia were comprised of individual investigators, research centers, studies, or other consortia and studied 48 different diseases or traits. Only 14 (25%) were found to have publicly accessible research guidelines on consortia websites. The available guidelines provide information on organization, governance, and research protocols; half address institutional review board approval. Details of publication, authorship, data-sharing, and intellectual property vary considerably. Wider access to consortia guidelines is needed to establish appropriate research standards with broad applicability to emerging forms of large-scale collaboration.
科学研究已经从单一研究者的研究转变为大型合作的创建。例如,遗传流行病学家现在广泛合作进行全基因组关联研究(GWAS)。其结果是一系列已确认的疾病-基因关联。然而,对于人类受试者监督、数据共享、出版和作者身份实践、研究组织和生产力以及知识产权的影响仍有待研究。本分析的目的是确定自 2005 年以来发表 GWAS 分析结果的所有研究合作组织,对其进行描述,确定哪些具有公开获取的研究实践指南,并总结这些指南中的政策。对国立人类基因组研究所已发表的全基因组关联研究目录的审查发现,截至 2011 年 4 月 1 日,有 55 个 GWAS 合作组织。这些合作组织由个别研究人员、研究中心、研究或其他合作组织组成,研究了 48 种不同的疾病或特征。只有 14 个(25%)在合作组织网站上找到了可公开获取的研究指南。现有的指南提供了有关组织、治理和研究方案的信息;其中一半涉及机构审查委员会的批准。出版、作者身份、数据共享和知识产权的细节差异很大。需要更广泛地获取合作组织指南,以建立适用于新兴大规模合作形式的广泛适用的适当研究标准。